Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Clinical symptoms associated with

Association of Pain, neuropathic pain is defined as pain initiated or caused by a primary lesion, dysfunction in the nervous system". Neuropathy can be divided broadly into peripheral and central neuropathic pain, depending on whether the primary lesion or dysfunction is situated in the peripheral or central nervous system. In the periphery, neuropathic pain can result from disease or inflammatory states that affect peripheral nerves (e.g. diabetes mellitus, herpes zoster, HIV) or alternatively due to neuroma formation (amputation, nerve transection), nerve compression (e.g. tumours, entrapment) or other injuries (e.g. nerve crush, trauma). Central pain syndromes, on the other hand, result from alterations in different regions of the brain or the spinal cord. Examples include tumour or trauma affecting particular CNS structures (e.g. brainstem and thalamus) or spinal cord injury. Both the symptoms and origins of neuropathic pain are extremely diverse. Due to this variability, neuropathic pain syndromes are often difficult to treat. Some of the clinical symptoms associated with this condition include spontaneous pain, tactile allodynia (touch-evoked pain), hyperalgesia (enhanced responses to a painful stimulus) and sensory deficits. [Pg.459]

Monitor clinical symptoms associated with hyperprolactinemia every month for the first 3 months to assess therapeutic efficacy and assist with dose titration. [Pg.719]

Understand the pathophysiology underlying the clinical symptoms associated with prostate cancer. [Pg.1357]

Vibragen Omega (r-feline interferon omega IFN-co) Virbac Reduction of mortality/clinical symptoms associated with canine parvovirus... [Pg.9]

In patients infected with HIV, many nonspecific and certain specific cellular immune functions can be shown to be altered or decreased, and a number of seemingly healthy individuals may exhibit marked immunological abnormalities without evidence of clinical illness. As the individual begins to exhibit clinical symptoms associated with AIDS, the abnormalities in the immune system become more extreme. A factor that complicates the study of HIV-induced immunosuppression is that many of the infections patients develop may themselves induce marked changes in the immune system. For this reason, it has been difficult to dissociate the fundamental changes associated with prolonged HIV infection from epiphenomena caused by other infections. One basic defect in the immune system of HIV-infected patients has, however, been elucidated. This is the loss of function and ultimate destruction of a proportion of T lymphocytes. [Pg.204]

What are some of the major clinical symptoms associated with allergy ... [Pg.184]

Scombroid refers to a complex of clinical symptoms associated with ingestion of improperly handled or stored fish from the Scombroidae family mahi mahi, bluefish, Bombay duck, kahawai, kingfish, swordfish, pacific amber)ack, salmon, tuna, bonito. [Pg.2354]

The y- and 5-chain mutants are difficult to study because of the small fraction of HbF and HbA2 present in adult erythrocytes. Overt clinical symptoms associated with y- and 5-chain variants are rare. By routine screening, 14 5-globin variants have been discovered but are of no clinical consequence. Thirty-five mutant y sequences (involving the Gy or the Ay chains) have been identified. They are all benign except for HbF Poole [Gyl30(H8) Tyr —> Gly], an unstable hemoglobin that causes hemolytic disease in the newborn. [Pg.670]

Glucocorticoids inhibit the initial steps in allograft rejection. They also aid in reversing the clinical symptoms associated with rejection. [Pg.1613]

C. Manifest Phase. This phase presents with the clinical symptoms associated with the major organ system injured (marrow, intestine, neurovascular system). A summary of essential features of each syndrome and the doses at which they would be seen in young healthy adults exposed to short, high dose single exposures is shown in Figure 6-1 of Part I of FM 8-9. [Pg.50]

Fig. 23.1. Pyrimidine pathways Pathways for the de novo synthesis, interconversion, and breakdown of pyrimidine ribonucleotides, indicating their metabolic importance as the essential precursors of the pyrimidine sugars and, with purines, of DNA and RNA. Note that in contrast to purines salvage takes place at the nucleoside not the base level in human cells and pyrimidine metabolism normally lacks any detectable end-product. The importance of this network is highlighted by the variety of clinical symptoms associated with the possible enzyme defects indicated. 23.10, Uridine monophosphate synthase (UMPS), 23.11a, uridine monophosphate hydrolase 1 (UMPHl), 23.12, thymidine phosphorylase (TP), 23.13, dihydropyrimidine dehydrogenase (DPD), 23.14, dihydropyrimidine amidohydrolase (DHP), 23.15, y -ureidopropionase (UP) (23.11b, UMPH superactivity specific to fibroblasts is not shown). CP, carbamoyl phosphate. The pathological metabolites used as specific markers in differential diagnosis are highlighted... Fig. 23.1. Pyrimidine pathways Pathways for the de novo synthesis, interconversion, and breakdown of pyrimidine ribonucleotides, indicating their metabolic importance as the essential precursors of the pyrimidine sugars and, with purines, of DNA and RNA. Note that in contrast to purines salvage takes place at the nucleoside not the base level in human cells and pyrimidine metabolism normally lacks any detectable end-product. The importance of this network is highlighted by the variety of clinical symptoms associated with the possible enzyme defects indicated. 23.10, Uridine monophosphate synthase (UMPS), 23.11a, uridine monophosphate hydrolase 1 (UMPHl), 23.12, thymidine phosphorylase (TP), 23.13, dihydropyrimidine dehydrogenase (DPD), 23.14, dihydropyrimidine amidohydrolase (DHP), 23.15, y -ureidopropionase (UP) (23.11b, UMPH superactivity specific to fibroblasts is not shown). CP, carbamoyl phosphate. The pathological metabolites used as specific markers in differential diagnosis are highlighted...
Identify clinical signs and symptoms associated with acute otitis media, bacterial rhinosinusitis, and streptococcal pharyngitis. [Pg.1061]

Clinical features associated with extrapulmonary TB vary depending on the organ system(s) involved but typically consist of slowly progressive decline of organ function with low-grade fever and other constitutional symptoms. [Pg.546]

As the first SNRI drug approved, venlafaxine has become one of the first-line choices for depression and anxiety disorder [45,46]. An active metabolite, desvenlafaxine (19), is also under clinical development for the treatment of major depressive disorders [47], Preclinical studies also indicate that 19 may be effective in relieving vasomotor symptoms associated with menopause (e.g., hot flushes and night sweats) [47,48]. Desvenlafaxine is reported to be in clinical development for the treatment of fibromyalgia and neuropathic pain, as well as vasomotor symptoms associated with menopause [68]. [Pg.19]

Dementia, a clinical syndrome associated with a variety of distinct pathological causes, is characterized by deterioration in multiple areas of higher intellectual function. As a result, it interferes with the ability to carry out routine daily activities. The symptoms of dementia fall into three categories intellectual (cognitive) deterioration, functional decline, and behavioral/emotional complications. [Pg.283]

Moderate to severe vasomotor symptoms associated with menopause - Use the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual women. Periodically reevaluate patients as clinically appropriate (eg, at 3-month to 6-month intervals) to determine if treatment is still necessary. The single approved dose of estradiol topical emulsion is 3.48 g/day. The lowest effective dose for this indication has not been determined. [Pg.173]

Medical personnel who work in affluent areas are unlikely to see large numbers of people with vitamin deficiency diseases. However, certain groups of the population are particularly at risk, such as low-income families and chronically ill patients. The classic symptoms of any vitamin deficiency disease as observed in laboratory animals are often blurred in humans. The clinical picture is often complicated by deficiencies of other vitamins, minerals, calories, and protein and by infections and parasite infestations, which usually accompany longstanding malnutrition. Biochemical, physiological, and behavioral changes can occur in the marginal deficiency state without or before the appearance of more specific symptoms. Since the nonspecificity of these changes makes them difficult to detail, this section focuses on the symptoms associated with individual vitamin deficiency diseases. [Pg.778]

BZDs differ considerably in potency, which refers to the milligram dose needed to produce a given clinical effect. These differences are in part due to differences in receptor site affinity. If given in the appropriate dose, any BZD may exert anxiolytic, hypnotic, or anticonvulsant effects. For example, anxiolytic BZDs, such as clorazepate and diazepam, are often used as hypnotics when anxiety is a prominent symptom associated with insomnia. [Pg.242]


See other pages where Clinical symptoms associated with is mentioned: [Pg.408]    [Pg.98]    [Pg.449]    [Pg.91]    [Pg.68]    [Pg.2179]    [Pg.1878]    [Pg.194]    [Pg.229]    [Pg.449]    [Pg.218]    [Pg.27]    [Pg.408]    [Pg.98]    [Pg.449]    [Pg.91]    [Pg.68]    [Pg.2179]    [Pg.1878]    [Pg.194]    [Pg.229]    [Pg.449]    [Pg.218]    [Pg.27]    [Pg.391]    [Pg.42]    [Pg.405]    [Pg.762]    [Pg.93]    [Pg.265]    [Pg.214]    [Pg.104]    [Pg.39]    [Pg.236]    [Pg.430]    [Pg.278]    [Pg.205]    [Pg.695]    [Pg.111]    [Pg.242]    [Pg.236]    [Pg.266]   


SEARCH



© 2024 chempedia.info